Morris Stephen J, Van-Ham Irit Itzhaki, Daigle Mireille, Robillard Liliane, Sajedi Naghmeh, Albert Paul R
Ottawa Health Research Institute (Neuroscience), University of Ottawa, 451 Smyth Road, Ottawa, Canada K1H-8M5.
Eur J Pharmacol. 2007 Dec 22;577(1-3):44-53. doi: 10.1016/j.ejphar.2007.08.027. Epub 2007 Aug 25.
Altered regulation of dopamine D(2) receptors is implicated in addiction, schizophrenia and movement disorders, as well as lactotroph growth and regulation. Dopamine D(2S) and dopamine D(2L) receptors are alternately-spliced variants that differ by 29 amino acids in the third intracellular (i3) domain and display different sensitivity to desensitization by protein kinase C (PKC). In the present studies we determined the specific phosphorylation sites on the dopamine D(2S) receptor that confer PKC-mediated desensitization. In dopamine D(2L) receptors, we identified a PKC pseudosubstrate site responsible for the relative insensitivity of the receptor to PKC-induced uncoupling. In transiently transfected Ltk(-) fibroblast cells, 2-min preactivation of PKC with 12-O-tetradecanoyl 4beta-phorbol 13alpha-acetate (TPA) completely inhibited calcium mobilization induced by the dopamine D(2S) receptor, but not the dopamine D(2L) variant. Point mutation of i3 PKC sites Ser228/229Gly rendered the dopamine D(2S) receptor resistant to PKC action, with lesser effects of other Ser and Thr mutations. Inactivation of the PKC pseudosubstrate motif in the dopamine D(2L) receptor sensitized the receptor to PKC, and this was reversed by mutation of i3 PKC sites Ser228/229. A phospho-specific antibody generated against phospho-Ser228/229 demonstrated PKC-induced phosphorylation at these sites of dopamine D(2S), but not D(2L) receptors, in Ltk(-) cells. Conversely, the pseudosubstrate dopamine D(2L) receptor mutant displayed PKC-induced phosphorylation at Ser228/229, which was abolished when these sites were mutated. Similar phosphorylation results were observed using GH4 cells stably transfected with dopamine D(2) receptors and mutants. Thus the relative location of phosphorylation and pseudosubstrate sites provides an important determinant substrate sensitivity to PKC.
多巴胺D(2)受体调节异常与成瘾、精神分裂症、运动障碍以及催乳素细胞生长和调节有关。多巴胺D(2S)和多巴胺D(2L)受体是交替剪接变体,在第三个细胞内(i3)结构域中相差29个氨基酸,并且对蛋白激酶C(PKC)脱敏表现出不同的敏感性。在本研究中,我们确定了多巴胺D(2S)受体上赋予PKC介导脱敏作用的特定磷酸化位点。在多巴胺D(2L)受体中,我们鉴定出一个PKC假底物位点,该位点导致受体对PKC诱导的解偶联相对不敏感。在瞬时转染的Ltk(-)成纤维细胞中,用12-O-十四烷酰4β-佛波醇13α-乙酸酯(TPA)对PKC进行2分钟预激活,可完全抑制多巴胺D(2S)受体诱导的钙动员,但对多巴胺D(2L)变体无此作用。i3 PKC位点Ser228/229突变为Gly使多巴胺D(2S)受体对PKC作用产生抗性,其他Ser和Thr突变的影响较小。多巴胺D(2L)受体中PKC假底物基序的失活使受体对PKC敏感,而i3 PKC位点Ser228/229的突变可使其恢复。针对磷酸化Ser228/229产生的磷酸特异性抗体表明,在Ltk(-)细胞中,PKC可诱导多巴胺D(2S)受体而非D(DL)受体在这些位点发生磷酸化。相反,假底物多巴胺D(2L)受体突变体在Ser228/229处表现出PKC诱导的磷酸化,当这些位点突变时,磷酸化被消除。使用稳定转染多巴胺D(2)受体及其突变体的GH4细胞也观察到了类似的磷酸化结果。因此,磷酸化位点和假底物位点的相对位置是决定底物对PKC敏感性的重要因素。